SLATE PATH CAPITAL LP – Eiger BioPharmaceuticals, Inc. Transaction History
SLATE PATH CAPITAL LP portfolio value:
$1.92M
portfolio value
SLATE PATH CAPITAL LP quarter portfolio value change:
+19.52%
quarter
Eiger BioPharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 313K | $7.53 | 255K | |
| Q2 2022 | share | 0.00% | 0 shares | -510K | $6.3 | 255K | |
| Q1 2022 | share | Increase | 0.00% | 255K shares | 2.11M | $8.3 | 255K |